Quinone Derivatives Modulating Ferroptosis for Oxidative Stress
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for diseases related to oxidative stress, such as ferroptosis, lack effective therapeutic options, particularly for conditions like acute kidney injury and epilepsy, where existing drugs are insufficient or ineffective for a significant portion of patients.
Innovation Solution
Development of quinone derivatives and their pharmaceutical compositions that modulate ferroptosis by acting as ferroptosis modulators, administered to patients to reduce reactive oxygen species and treat oxidative stress-related disorders.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing drugs are used to treat oxidative stress-related diseases, then some patients may experience therapeutic effects, but a significant portion of patients (e.g., 20-30% of epilepsy patients, 30% of AKI patients) remain resistant or receive insufficient treatment
Solution Approach 1:
The patent introduces a novel class of compounds (quinone derivatives with specific structural formulas) that represent a fundamental change in the chemical parameter space of therapeutic agents. These compounds exhibit unique mechanisms of action as ferroptosis modulators, differing from existing drugs, thereby providing effective treatment for patients who are resistant to conventional therapies.
2Adaptability or versatility
If new ferroptosis modulator compounds are developed to expand treatment options, then more patients can be treated effectively, but the complexity of drug development and characterization increases
Solution Approach 1:
The patent systematically segments the development process into distinct components: defining specific chemical structures (Formulas I and II), establishing structure-activity relationships, identifying key biological activities (ferroptosis modulation), and determining therapeutic applications. This segmentation provides a clear framework that guides drug development while expanding treatment options.
Solution Approach 2:
The quinone derivative compounds exhibit multi-functionality as they can treat multiple oxidative stress-related diseases including epilepsy, acute kidney injury, and other conditions. This universal applicability across different disease indications maximizes the therapeutic value of the developed compounds while justifying the investment in their complex development.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The quinone derivatives effectively modulate ferroptosis, providing a potential therapeutic approach for treating oxidative stress-related diseases, including acute kidney injury and epilepsy, by reducing ROS levels and alleviating symptoms.
Implementation Method 1
the compositions and methods comprise administrating an effective amount of a compound that is a ferroptosis modulator... excessive flux of unrestrained ROS leads to cellular dysfunctions and/or death... the loss of glutathione peroxidase 4 (GPx4) activity allows for a lethal excess of ROS which then leads to cellular destruction by oxidative stress
Data Source
AI summary
Compounds of Formula (I)a or (I)b:including certain quinone derivatives, and the corresponding pharmaceutical compositions, which may serve to modulate ferroptosis in a subject. Also disclosed herein are the preparations of these compounds and pharmaceutical compositions and their potential uses in the manufacture of a medicament in reducing reactive oxygen species (ROS) in a cell and for preventing, treating, ameliorating certain related disorder or a disease.